Stuart J
J Clin Pathol. 1985 Sep;38(9):965-77. doi: 10.1136/jcp.38.9.965.
Erythrocyte deformability was formerly measured by its contribution to whole blood viscosity. It is now more commonly measured by filtration of erythrocytes through, or aspiration into, pores of 3-5 microns diameter and by the measurement of shear induced erythrocyte elongation using laser diffractometry. Recent improvements in the technology for erythrocyte filtration have included the removal of acute phase reactants from test erythrocyte suspensions, ultrasonic cleaning and reuse of filter membranes, awareness of the importance of mean cell volume as a determinant of flow through 3 microns diameter pores, and the ability to detect subpopulations of less deformable erythrocytes. Measurements of erythrocyte elongation by laser diffractometry, using the Ektacytometer, are also influenced by cell size and need to be corrected for mean cell volume. These advances have greatly improved the sensitivity and specificity of rheological methods for measuring the deformability of erythrocytes and for investigating the mode of action of rheologically active drugs.
红细胞变形性以前是通过其对全血粘度的影响来测量的。现在更常用的方法是通过让红细胞通过直径为3 - 5微米的孔进行过滤或吸入,以及使用激光衍射法测量剪切诱导的红细胞伸长来测量。红细胞过滤技术最近的改进包括从测试红细胞悬液中去除急性期反应物、超声清洗和重复使用滤膜、认识到平均细胞体积作为通过3微米直径孔的流量决定因素的重要性,以及检测变形性较差的红细胞亚群的能力。使用激光衍射仪通过Ektacytometer测量红细胞伸长也受细胞大小影响,需要对平均细胞体积进行校正。这些进展极大地提高了测量红细胞变形性和研究流变活性药物作用方式的流变学方法的灵敏度和特异性。